- “FDA report urges strong acetaminophen warning” (Chicago Tribune)
- “Solvay to get bids for drug unit Friday: sources” (Reuters)
- “Celleron secures rights to AstraZeneca cancer candidate” (Pharma Times)
- “Eastbourne sees dissident gains on Amylin board” (Reuters)
- “Bayer, J&J say FDA wants more data on Xarelto” (Reuters)
- “FDA Is Reviewing Ranbaxy’s Corrective Plan on Drugs to the U.S.” (Bloomberg)
- “Bayer, Roche test drug pair against liver cancer” (Reuters)
- “Novartis, Roche unveil promising cancer drugs data” (Reuters)
- “Sanofi-Aventis in cancer drug deal with Exelixis” (Reuters)
- “Drugmaker to pay nearly $100 million settlement” (The Associated Press)
- “J&J files for arbitration over Schering deal” (Forbes, The Associated Press)
SUBSCRIBE